Krista Rossi

First-line avelumab monotherapy treatments show efficacy in patients with Merkel cell carcinoma (mMCC).

AbbVie won’t seek accelerated approval for Rovalpituzumab Tesirine in third-line relapsed/refractory small cell lung cancer due to the low percentages in efficacy in the TRINITY study.

A recent study suggests low doses of oral cyclosporine A do not prevent second-eye involvement in adult patients with unilateral Leber’s hereditary optic neuropathy (LHON).

Positive data was anounced regarding PBI-4050, a possible treatment for Alström syndrome.